Amgen Financials - Benzinga

Amgen Inc

AMGNNASDAQ

Trade with Public

Trade with Public

$438.59

-0.35-0.08%

最終更新: Oct 21, 9:26 AM

$438.59

-0.35-0.08%

概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

© 2026 Benzinga | All Rights Reserved

Amgen Financials

Amgen (AMGN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Amgen Narrows FY2026 GAAP EPS Guidance from $15.62-$17.10 to $15.80-$17.08 vs $15.44 Est

Amgen (NASDAQ:AMGN) narrows FY2026 GAAP EPS guidance from $15.62-$17.10 to $15.80-$17.08 vs $15.44 analyst estimate..

Benzinga Newsdesk

PRO
Amgen Raises FY2026 Adj EPS Guidance from $21.70-$23.10 to $22.30-$23.50 vs $22.35 Est; Raises FY2026 Sales Guidance from $37.100B-$38.500B to $38.200B-$39.400B vs $37.741B Est

Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $21.70-$23.10 to $22.30-$23.50 vs $22.35 analyst estimate. Raises FY2026 sales outlook from $37.100 billion-$38.500 billion to $38.200 billion-$39.400 billion vs

Benzinga Newsdesk

PRO
Amgen Q2 Adj. EPS $6.29 Beats $5.62 Estimate, Sales $10.054B Beat $9.421B Estimate

Amgen (NASDAQ:AMGN) reported quarterly earnings of $6.29 per share which beat the analyst consensus estimate of $5.62 by 11.92 percent. This is a 4.49 percent increase over earnings of $6.02 per share from the same

Benzinga Newsdesk

PRO
Update: Amgen Raises FY2026 Adj EPS Guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 Est; Raises FY2026 Sales Guidance from $37.000B-$38.400B to $37.100B-$38.500B vs $37.807B Est

Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 analyst estimate. Raises FY2026 sales outlook from $37.000 billion-$38.400 billion to $37.100 billion-$38.500 billion vs

Benzinga Newsdesk

PRO
Amgen Raises FY2026 Adj EPS Guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 Est

Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 analyst estimate..

Benzinga Newsdesk

PRO
Amgen Raises FY2026 GAAP EPS Guidance from $15.45-$16.94 to $15.62-$17.10 vs $15.18 Est

Amgen (NASDAQ:AMGN) raises FY2026 GAAP EPS guidance from $15.45-$16.94 to $15.62-$17.10 vs $15.18 analyst estimate..

Benzinga Newsdesk